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Regulated intramembrane proteolysis is a
method for transducing signals betweencellular
compartments. When protein folding is com-
promised in the periplasm of E. coli, the C ter-
mini of outer-membrane proteins (OMPs) bind
to the PDZ domains of the trimeric DegS prote-
ase and activate cleavage of RseA, a transmem-
brane transcriptional regulator. We show here
that DegS is an allosteric enzyme. OMP binding
shifts the equilibrium fromanonfunctional state,
in which the active sites are unreactive, to the
functional proteolytic conformation. Crystallo-
graphic, biochemical, and mutagenic experi-
ments show that the unliganded PDZ domains
are inhibitory and suggest that OMP binding
per se is sufficient to stabilize the relaxed con-
formation and activate DegS. OMP-induced
activation and RseA binding are both positively
cooperative, allowing switch-like behavior of
theOMP-DegS-RseAsystem.Residues involved
in the DegS allosteric switch are conserved in
the DegP/HtrA andHtrA2/Omi families, suggest-
ing that many PDZ proteases use a common
mechanism of allosteric activation.
INTRODUCTION
Regulated intramembrane proteolysis (RIP) mediates sig-
nal transduction between different membrane-bounded
cellular compartments in all domains of life (Brown et al.,
2000). RIP systems require two proteases. The first prote-
ase senses an initial signal and responds by cleaving a
transmembrane protein on one side of a membrane (site-1
cleavage). In response, the second protease cleaves the
same regulatory protein on the other side of the mem-
brane (site-2 cleavage), allowing signal propagation.
Although RIP systems are ubiquitous, the detailed mech-
anisms by which regulated intramembrane proteolysis is
modulated remain largely undetermined.
In Escherichia coli, envelope or periplasmic stress initi-
ates a RIP cascade in which the protease DegS and trans-572 Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc.membrane regulator RseA play key roles (for review, see
Raivio and Silhavy, 2001; Alba and Gross, 2004; Ehrmann
and Clausen, 2004). When protein folding and assembly
in the periplasm are compromised or outer-membrane
proteins (OMPs) are overexpressed, DegS cleaves the
periplasmic domain of RseA, activating site-2 cleavage
by protease RseP (Mecsas et al., 1993; Ades et al.,
1999; Alba et al., 2001, 2002; Kanehara et al., 2002;
Akiyama et al., 2004). The cytoplasmic N-terminal domain
of RseA normally binds and inhibits the sE transcription
factor (De Las Penas et al., 1997; Missiakas et al., 1997;
Campbell et al., 2003). However, site-2 cleavage releases
N-RseAsE from the membrane, allowing N-RseA to be
degraded by cytoplasmic proteases (Flynn et al., 2004;
Chaba et al., 2007). This final degradation step frees sE,
allowing it to bind RNA polymerase and enhance tran-
scription of genes for periplasmic chaperones, proteases,
and biosynthetic enzymes (Rhodius et al., 2006).
How does DegS—a trimer of identical subunits, each
with a membrane anchor, a trypsin-like protease domain,
and a PDZ domain—sense the initiating signal for enve-
lope stress? Peptides with C-terminal YxF sequences
(where ‘‘x’’ can be many residues) bind the PDZ domain
of DegS, activate DegS cleavage of the V148-S149 pep-
tide bond of RseA in vitro, and induce the envelope-stress
response in vivo (Walsh et al., 2003). YxF is the C-terminal
sequence of many OMPs but is sequestered in properly
assembled OMPs, suggesting that DegS senses envelope
stress by binding misfolded or unassembled OMPs. There
are competing activation models. Because a DegS6PDZ
variant showed some activity in vivo, it was proposed
that peptide binding reverses an inhibitory activity of the
PDZ domain (Walsh et al., 2003). Indeed, recent work
shows that DegS6PDZ and intact DegS cleave RseA to
comparable extents in an end-point assay (Cezairliyan
and Sauer, 2007). Inferences from crystal structures sug-
gested a different model (Wilken et al., 2004), namely that
the PDZ domain serves as a scaffold, presenting a bound
OMP peptide in a manner that allows its penultimate side
chain to contact the DegS protease domain and propa-
gate conformational changes to the active site. These
models make distinct predictions and have different bio-
logical implications. For example, if the penultimate pep-
tide residue is critical for proper activation, then only a
subset of unassembled OMPs or other periplasmic pro-
teins will initiate the envelope-stress response. Moreover,
peptides that bind but do not activate would play inhibitory
roles. By contrast, if any peptide that binds to the PDZ
domain also activates DegS, then integration of a wide
variety of input signals would be possible.
Many proteases contain PDZ domains (Clausen et al.,
2002; Kim and Kim, 2005). For example, DegS shares
strong sequence and structural homology with human
HtrA2/Omi, a mitochondrial PDZ protease that is released
into the cytoplasm during apoptosis and contributes to
caspase-independent cell death (Li et al., 2002; Salelens
et al., 2004). Moreover, the E. coli site-2 RseP protease,
as well as the periplasmic proteases DegP, DegQ, and
Tsp, contain one or two PDZ domains. Thus, understand-
ing how PDZ domains regulate protease activity is a prob-
lem of broad significance. The OMP-DegS-RseA system
could serve as an important paradigm. Structures of un-
liganded DegS and the peptide-bound enzyme are known
(Wilken et al., 2004; Zeth, 2004), making it the best charac-
terized PDZ protease from a structural perspective. How-
ever, published assays for DegS activity are not easily
quantified, employ similar quantities of enzyme and sub-
strate, and require long incubations (Walsh et al., 2003).
Thus, themechanism of OMP activation of DegS cleavage
of RseA has yet to be rigorously investigated.
Using improved quantitative assays, we show here that
DegS behaves as a classical allosteric enzyme. The bind-
ing of OMP peptides shifts the equilibrium from an inactive
state, in which the active site is unreactive, to a functional
proteolytic conformation. Allostery gives rise to positive
cooperativity in the activation of DegS by OMP peptides.
A different mechanism, substrate-substrate interactions,
mediates positive cooperativity in RseA binding to DegS.
We present evidence that the unliganded PDZ domain
of DegS is inhibitory. DegS6PDZ and DegS cleave RseA
with similar steady-state kinetics, and the crystal structure
of DegS6PDZ resembles the protease domain of active
peptide-bound DegS. Detailed studies of mutant variants
of DegS, DegS6PDZ, and OMP peptides are also inconsis-
tent with several predictions of the proposed scaffold
model for DegS activation. Rather, we suggest that activa-
tion occurs when any YxF or related peptide sequence
binds preferentially to the relaxed or active conformation
of DegS. We find that a residue conserved in DegS,
DegP, DegQ, andHtrA2 plays a critical role in the allosteric
switch between the inactive and active states of the pro-
tease, suggesting that many PDZ proteases use a com-
mon allosteric mechanism of peptide activation.
RESULTS
A Quantitative Assay for DegS Cleavage of RseA
For this work, we used a soluble DegS variant with an
N-terminal His6 tag and no membrane anchor. Previous
studies showed that this variant (called DegS for simplic-
ity) cleaved the periplasmic domain of RseA (residues
121–216; RseAperi) at a single site when OMP peptide
was present (Walsh et al., 2003). We found that the re-
action time could be reduced from hours to minutes byoptimizing conditions and that cleavage of 35S-labeled
RseAperi could be quantified by an acid-precipitation as-
say (see Experimental Procedures). These assay condi-
tions did not alter the reaction products or dependence
on OMP peptide (Figure 1A) and gave linear initial rates
that were proportional to DegS concentration (Figures
1B and 1C).
Cooperative Dependence of DegS Cleavage
on RseA Concentration
To determine steady-state kinetic parameters, we as-
sayed initial rates of DegS cleavage of different concentra-
tions of RseAperi in the presence of saturating YYF-OMP
peptide. The Michaelis-Menten plot was sigmoid (Fig-
ure 1D, upper panel; Hill constant 1.6 ± 0.2), suggesting
that binding of one RseA molecule to the DegS trimer
strengthens binding of other substrates. Favorable sub-
strate-substrate interactions could be responsible for the
observed positive cooperativity, or substrate binding
could stabilize a higher-affinity conformation of DegS
allosterically.
The maximum velocity or turnover number for DegS
cleavage of RseA (1.1 ± 0.2 s1 DegS3
1) was fast enough
to account for the fact that intracellular RseA levels drop
within minutes of a stress signal (Ades et al., 1999). The
apparent KM (750 ± 120 mM) was about 10-fold higher
than estimates for RseA levels in the periplasm (80 mM)
(Grigorova et al., 2006; Cezairliyan and Sauer, 2007). In
our soluble system, the initial rate of DegS cleavage of
80 mM RseA was roughly 1.2 molecules per min per en-
zyme. If we assume that comparable rates occur in vivo,
then a DegS concentration of 20 mM would account for
the observed kinetics of the response in vivo. Alternatively,
enzyme-substrate binding in the cell could be tighter
because DegS and RseA are both membrane bound.
The PDZ Domain Is Not Required for Efficient
RseAperi Cleavage
In the absence of OMP peptide, a DegS variant lacking the
PDZ domain (DegS6PDZ) cleaved RseAperi with steady-
state kinetic parameters (KM = 570 ± 50 mM; Vmax = 0.8 ±
0.1 s1 DegS6PDZ3
1; Hill constant = 1.8 ± 0.2; Figure 1D,
lower panel) similar to those determined for intact DegS
plus OMP peptide. Addition of OMP peptide did not
change the rate of cleavage of RseAperi by DegSDPDZ
(data not shown), whereas cleavage by full-length DegS
was very slow in the absence of activating peptide (see
below). These results show that the PDZ domain in intact
DegS plays an inhibitory role and that neither the PDZ
domain nor OMP peptide is needed for efficient cleavage
of RseA.
Substrate cleavage by DegSDPDZ showed the same
cooperative dependence on substrate concentration as
intact DegS (Figure 1D). If DegSDPDZ is already in an active
conformation, however, then allostery cannot be respon-
sible for the cooperativity of substrate cleavage. Hence,
interactions between enzyme-bound RseAperi substrates
probably explain the observed positive cooperativity.Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc. 573
Figure 1. Control of DegS Cleavage of
RseA by OMP Peptide and the PDZ
Domain
(A) SDS-PAGE assay of cleavage of RseAperi
(70 mM) by DegS (4 mM trimer). The cleavage
reactions in lanes 1–3 were performed in
150 mM NaPHO4 (pH 8.3), 380 mM NaCl,
10% glycerol, and 4 mM EDTA for 10 min. The
reactions in lanes 4 and 5 were performed in
50 mM NaHPO4 (pH 7.4), 200 mM KCl, and
10%glycerol) for 3 hr. In lane 3, the AA RseAperi
substrate contains the V148A/S149A muta-
tions. YYF peptide (30 mM) was present in the
reactions shown in lanes 1, 3, and 4. Cleavage
reactions were stopped by addition of 2 vol-
umes of 33 Laemmli buffer and boiling. The
gel was stained with Coomassie Blue.
(B) Linear kinetics (R2 > 0.98) of DegS cleavage
of RseAperi (200 mM) in the presence of 40 mM
YYF-OMP peptide.
(C) Cleavage rates from panel (B) plotted as
a function of DegS concentration.
(D) Michaelis-Menten plots of initial rates of
RseAperi cleavage by DegS (0.7 mM trimer) in
the presence of 40 mM YYF-OMP peptide (up-
per panel) or DegSDPDZ (0.6 mM trimer; lower
panel). The solid lines are nonlinear least-
squares fits of the data to theHill formof theMi-
chaelis-Menten equation: rate = Vmax/(1+(KM/
[substrate])n). The data shown are representa-
tive of three independent determinations.
(E) The rate of cleavage of 35S-RseAperi
(200 mM) by DegS (0.8 mM trimer) with 40 mM
YYF peptide or by DegSDPDZ (0.8 mM trimer)
was determined in the presence of increasing
amounts of unlabeled AA-RseAperi.
(F) Michaelis-Menten plot of initial rates of
RseAperi-YQF fusion substrate cleavage by
DegS (0.2mMtrimer) in theabsenceofadditional
OMP peptide. The solid line is a fit of the data to
the hyperbolic form of the Michaelis-Menten
equation: rate = Vmax/(1+KM/[substrate]).We mutated the V148-S149 sequence flanking the
DegS cleavage site in RseAperi to A148-A149 (AA-
RseAperi) and found that this mutant was cleaved far
more slowly by DegS (Figure 1A). When we titrated AA-
RseAperi and assayed DegS or DegSDPDZ cleavage of
35S-RseAperi, we observed activation at low AA-RseAperi
concentrations and inhibition at high concentrations
(Figure 1E). Activation can be rationalized if binding of
one AA-RseAperi molecule to a DegS trimer strengthens
binding of one or two molecules of the RseAperi substrate.
At high concentrations of AA-RseAperi, too many DegS
subunits are occupied by the poorly cleaved variant and
binding of the labeled substrate is inhibited.
A Self-Activating Substrate for DegS
TheRseAperi cleavage ratewasnot saturatedat the highest
soluble substrate concentration (1.5 mM; Figure 1C). To
obtain a tighter-binding substrate, we fused theC-terminal
tripeptide of E. coli OmpC (YQF) to the C terminus of
RseAperi, reasoning that this fusion substrate would bind574 Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc.more tightly by tethering itself to the PDZ domain of DegS
and also be self activating. As anticipated, theKMwas sub-
stantially lower (33 ± 5 mM) and saturation of the DegS
cleavage rate was readily achieved in the absence of
added OMP peptide (Figure 1F). Surprisingly, however,
the Michaelis-Menten plot was not sigmoid and positively
cooperative but was hyperbolic. This result suggests that
the fusion substrate interacts with DegS in a manner that
precludes favorable substrate-substrate interactions.
Binding of theC termini of fusion substrates to the PDZdo-
mains might prevent favorable interactions. Alternatively,
bindingofone fusionsubstratemight blockbindingof other
fusion substrates. DegS6PDZ cleaved low concentrations
of the fusion substrate at the same rate as it cleaved
RseAperi, demonstrating that enhanced DegS cleavage of
the fusion substrate is PDZ dependent (data not shown).
Allosteric Activation by OMP Peptide
Using fixed amounts of DegS andRseAperi, we determined
the cleavage rate as a function of YYF-OMP-peptide
Figure 2. Activation and Inhibition of
DegS Protease Activity
(A) Second-order rate constants for cleavage
of RseAperi (200 mM) by DegS (0.13 mM trimer)
are plotted as a function of the concentration
of YYF-OMP peptide. The solid line is a fit to
the equation rate = basal + stimulated/
(1+(Kact/[YYF])
n).
(B) Binding of DegS or the isolated PDZ domain
of DegS to a fluorescein-modified YYF peptide
was monitored by changes in fluorescence an-
isotropy. The fraction bound was calculated as
(A-Ao)/(Amax-Ao), where Ao is the anisotropy of
the free peptide and Amax is the anisotropy
with saturating protein. The solid lines are fits
to a quadratic form of a hyperbolic binding iso-
therm.
(C) Activation by different YxF peptides of the
cleavage of RseAperi (200 mM) by DegS (0.14-
0.6 mM trimer). The solid lines are fits to the
equation in the panel-(A) legend.
(D) Cleavage of RseAperi (150 mM) by DegS
(1 mM trimer) was inhibited by DFP in the pres-
ence but not the absence of OMP peptide.
RseAperi cleavage by DegSDPDZ (1 mM trimer)
was inhibited by DFP in the absence of OMP
peptide. The values shown are means of three
trials (error% 15%).concentration. DegS displayed a very low basal rate
of cleavage in the absence of OMP peptide (2.9 ± 0.5
M1s1), which increased about 230-fold at high YYF-
peptide concentrations (Figure 2A). Based upon replicate
measurements, half-maximal activation of DegS cleavage
occurred at a YYF-peptide concentration of 3.9 ± 0.8 mM
and the Hill constant was 1.9 ± 0.2, a signature of positive
cooperativity. In the crystal structure of the peptide-
bound DegS trimer (1soz), the OMP peptides are 50–60
A˚ apart (Wilken et al., 2004) (see Figure 3A), ruling out
favorable peptide-peptide interactions as the cooperativ-
ity source. Hence, YYF-peptide binding appears to favor
an allosteric change from a tense or inactive DegS con-
formation to a relaxed or active conformation that binds
peptide more tightly and is proteolytically active (Monod
et al., 1963, 1965).
DegS bound a fluorescein-modified YYF peptide half
maximally at a concentration of 4.6 ± 0.2 mM (subunit
equivalents; Figure 2B), in good agreement with the pep-
tide concentration required for half-maximal DegS activa-
tion (Figure 2A). However, the isolated PDZ domain of
DegS bound the fluorescein-YYF peptide more tightly
(KD = 0.64 ± 0.07 mM), a value within error of the binding
constant for an unmodified YYF peptide measured by
isothermal titration calorimetry (0.63 ± 0.1 mM; Walsh
et al., 2003). Together, these results suggest that tertiary
and quaternary interactions hold the PDZ domains in unli-
ganded DegS in a nonoptimal conformation for OMP-pep-
tide binding. This behavior is a hallmark of the concerted
and sequential models of allostery (Monod et al., 1965;
Koshland et al., 1966).Role of the Penultimate Residue in OMP Peptides
The peptide-scaffold model proposes that the penulti-
mate side chain of the PDZ-bound OMP peptide, by
making a contact with the L3 loop, plays a critical role in
driving a conformational change in the DegS protease
domain (Wilken et al., 2004). Although many penultimate
OMP-peptide residues were functional in their study,
Wilken et al. (2004) reported that small or negatively
charged side chains (e.g., YAF, YSF, and YDF) failed to
activate DegS. By contrast, we found that the YAF, YSF,
YDF, YQF, YRF, and YYF peptides all activated DegS
cleavage of RseAperi to roughly comparable extents, al-
though with varied apparent affinities (Table 1 and Figures
2A and 2C). As seen previously for the YYF peptide, DegS
binding to fluorescein-modified YAF and YQF peptides
correlated reasonably with the peptide concentration re-
quired for half-maximal activation, whereas the isolated
PDZ domain of DegS bound these peptides more tightly
(Table 1). We conclude that the chemical identity of the
penultimate residue of the OMP peptide plays a role in
establishing affinity for DegS but is not a principal determi-
nant of the activation mechanism. Hence, any protein with
an accessible YxF sequence at its C terminus could con-
tribute to DegS activation.
Active-Site Reactivity and OMP-Peptide Binding
Crystal structures suggest that the geometry of the oxyan-
ion hole and the DegS catalytic triad (H96, D126, and
S201) should not support protease activity in DegS with-
out bound OMP peptide (Wilken et al., 2004; Zeth,
2004). To test this hypothesis, we treated DegS andCell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc. 575
Figure 3. Structure
(A) Surface representation of a DegS trimer showing positions of the protease and PDZ domains, the active sites, and an YQF-OMP peptide. This
symmetric trimer was generated using three copies of the A chain of 1soz (Wilken et al., 2004). The actual 1soz trimer is asymmetric.
(B) Superposition of four independent structures of the DegSDPDZ trimer in cartoon representation. The LA loops (residues 65–75; pink), the LD loops
(residues 160–167; orange), the L3 loops (residues 176–189; red) and the L2 loops (residues 219–232) are colored differently from themain body of the
structure (blue-purple).
(C) Left panel: active sites in OMP-bound DegS (1soz_A) and DegSDPDZ (2QF3_A) are very similar. Right panel: active-site residues in free DegS
(1te0_A) and DegSDPDZ (2QF3_A) vary substantially. The alignments shown were obtained by aligning the 2QF3_A DegSDPDZ subunit with the
1soz_Asubunit (0.337 A˚ rmsd; 175 CA positions) or the 1te0_A subunit (0.906 A˚ rmsd; 176 CA positions).
(D) The ordered L3 loops from five DegSDPDZ subunits (red/brown) assume different conformations than the L3 loops from three subunits of OMP-
bound DegS (slate blue; 1soz). Although the R178 CA positions are very different in OMP-bound DegS and DegSDPDZ, the guanidinium groups of
these side chains occupy similar positions.
(E) Side-chain interactions between the PDZ domain of peptide-free DegS (red/brown) and the protease domain (slate blue) (1te0; Zeth, 2004). The
linker between these domains is colored cyan. Dashed lines indicate hydrogen bonds.
(F) The side chain of R178 from one subunit of DegSDPDZ (2QF3_B) hydrogen bonds to the Q191 side chain in the same subunit and to the carbonyl
oxygens of L164 and Q166 in the adjacent subunit (2QF3_A). The Q191 side chain also hydrogen bonds to the T167 side chain in the adjacent subunit.
Additional hydrogen bonds occur between the L164 NH and the P161 carbonyl oxygen, and between the Y162 NH and the carbonyl oxygen of H198.
This network connects the contacts made by R178 to the oxyanion hole of the active site. Dashed lines indicate hydrogen bonds. Graphics prepared
using PyMOL (DeLano, 2002).DegS6PDZ with diisopropylfluorophosphate (DFP), a pro-
tease inhibitor that covalently modifies active-site serines.
In the presence of OMP peptide, DFP inhibited DegS
completely within 10 min (Figure 2D). DegS6PDZ was in-
hibited with the same kinetics in the absence of peptide.
By contrast, no DFP inactivation of DegS was observed
over 10 min without OMP peptide (Figure 2D). Thus, the
active-site reactivity of intact DegS changes dramatically
upon OMP-peptide binding to the PDZ domain. This result
supports an allosteric model in which the unliganded PDZ
domains stabilize a nonfunctional DegS conformation.576 Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc.Without YYF peptide, no inhibition of DegS by DFP was
observed in the presence of 250 mM RseAperi (data not
shown). This finding suggests that RseA does not bind
preferentially to the relaxed state or that binding is too
weak to affect the tense-relaxed allosteric equilibrium at
this substrate concentration.
Crystal Structures of DegS6PDZ
We crystallized selenomethionine-substituted DegS6PDZ,
collected X-ray diffraction data to 2.5 A˚ resolution, deter-
mined SAD phases, and refined the structure (Table 2).
Table 1. OMP-Peptide Activation and Binding to DegS
C-Terminal Sequence
OMP-Peptide
Maximal Cleavage
Activity (M1 s1)
Half-Maximal
Activation (mM) Hill Constant
KD (mM)
for DegS
KD (mM) for
PDZ Domain
YYF 730 ± 80 3.9 ± 0.8 1.8 ± 0.2 4.6 ± 0.3 0.6 ± 0.2
YQF 590 ± 70 50 ± 5 1.6 ± 0.1 28 ± 4 15 ± 2
YRF 520 ± 80 40 ± 10 1.6 ± 0.2 ND ND
YSF 590 ± 80 90± 10 1.4 ± 0.1 ND ND
YAF 640 ± 60 190 ± 20 1.4 ± 0.1 130 ± 20 40 ± 5
YDF 610 ± 50 360 ± 30 1.7 ± 0.2 ND ND
ND, not determined. The parameters listed are means of at least two independent determinations. Errors were estimated asﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=ðn 1ÞPn1ðvaluemeanÞ2
q
, where n is the number of independent values.This crystal form (2QF0) contained three trimers per asym-
metric unit. Subsequently, we obtained a second crystal
form (2QF3) with one trimer per asymmetric unit and
solved this structure by molecular replacement (2.04 A˚;
Table 2). Together, these structures provide independent
views of four DegS6PDZ trimers and 12 DegS6PDZ sub-
units in distinct crystallographic environments.
The different DegS6PDZ trimers had similar structures
(<0.5 A˚ rmsd for main-chain atoms), with the biggest dif-
ferences occurring in the LA, L2, and L3 loops, which
were completely or partially disordered in many subunits(Figure 3B). In most DegS6PDZ subunits, the active-site
residues and the oxyanion hole resembled the corre-
sponding portion of peptide-bound DegS rather than pep-
tide-freeDegS (Figure 3C), although theH96 side chain as-
sumed different rotamer conformations in one subunit of
the 2QF0 structure. Nevertheless, these structural results
are in general accord with the functional results discussed
above and imply that the PDZ domains of DegS normally
hold the protease domains in an inactive conformation.
Parts of the DegS L3 loop (residues 176–189) contact
the PDZ domain in peptide-free DegS but assume aTable 2. Crystallographic Data and Refinement Statistics
Protein DegSDPDZ DegSDPDZ R178A DegSDPDZ
PDB Code 2QF0 2QF3 2QGR
Unit Cell P212121 P212121 H3
a = 71.2 A˚ a = 72.3 A˚ a = 70.2 A˚
b = 133.0 A˚ b = 75.3 A˚ b = 70.2 A˚
c = 229.3 A˚ c = 162.3 A˚ c = 119.2 A˚
Resolution 2.5 A˚ 2.04 A˚ 2.7 A˚
Wavelength 0.97918 A˚ 0.97949 A˚ 1.54178 A˚
Rsym 0.099 (0.439) 0.067 (0.468) 0.058 (0.201)
Unique Reflections 145473 (13929) 53038 (7339) 5938 (525)
Completeness (%) 99.2 (94.1) 92.8 (78.1) 98.8 (87.5)
Data Redundancy 6.0 (2.8) 6.7 (3.7) 10.2 (5.6)
I/sI 9.7 11.0 15.6
Rwork 0.216 (0.284) 0.189 (0.242) 0.280 (0.440)
Rfree 0.268 (0.323) 0.219 (0.283) 0.283 (0.448)
Protein Atoms 13450 4458 1222
Solvent Atoms 412 325 0
Average B Value 49.8 44.8 77.3
Rsym = ShSj jIj(h) <I(h)>j / ShSj <I(h)>, where Ij(h) is the jth reflection of index h and <I(h)> is the average intensity of all observations
of I(h).
Rwork = Sh jFobs(h) – Fcalc(h)j j / Sh jFobs(h)j, calculated over the 95% of the data in the working set. Rfree equivalent to Rwork
except calculated over the 5% of the data assigned to the test set.
Numbers in parentheses represent values for the highest resolution bin.Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc. 577
different conformation in the peptide-bound structure
(Wilken et al., 2004; Zeth, 2004). In our structures, signifi-
cant parts of the L3 loop were disordered in many sub-
units, but the L3 loops that were ordered assumed a differ-
ent conformation than observed in the peptide-bound
DegS structure (Figure 3D). Hence, the precise conforma-
tion of the entire L3 loop does not appear to be an impor-
tant determinant of ‘‘active’’ DegS structures. Wilken et al.
(2004) proposed that the peptide-bound L3-loop confor-
mation supported additional structural changes, including
formation of a hydrogen bond between the side chains of
E227 in the L2 loop and Y162 in the LD loop, which were
responsible for restructuring the active site. However,
the E227 side chain hydrogen bonded to the hydroxyl of
Y162 in only one of the 12 DegS6PDZ subunits and was
completely missing from the electron-density map in the
majority of subunits. Although these facts do not rule out
an important role for E227, they were surprising in light
of the high activity observed for DegS6PDZ.
Mutations at Y162, P183, and E227
In support of their activation model, Wilken et al. (2004)
reported that the Y162A and E227A mutants of DegS
were inactive. They also found that the L3-loop mutation
P183A, which affects a contact with the PDZ domain,
was inactive. Because our crystallographic results raised
questions about the importance of an E227-Y162 interac-
tion, we remade this set of three mutants as well as Y162F
and tested degradation of RseAperi and RseAperi-YQF. In
our assays, Y162A DegS had extremely low activity but
the P183A and E227A DegSmutants were about as active
or more active than the wild-type enzyme, respectively
(Figures 4A and 4B and Table 3). Moreover, we found
that the E227A and P183A mutants were also fully active
under the assay conditions used by Wilken et al. (2004)
(data not shown). Some DegS orthologs have phenylala-
nine at the position corresponding to Y162 in DegS. The
Y162F mutant had about 40% of wild-type activity (Fig-
ures 4A and 4B and Table 2), suggesting that the hydroxyl
group of Y162 plays some role in supporting the active
conformation of DegS. E227 and P183 are poorly con-
served in DegS orthologs. Thus, the activation model
proposed by Wilken et al. (2004) could not apply generally
to the broader DegS family and also fails to explain the
phenotypes of mutants in E. coli DegS.
Allosteric Determinants of PDZ Inhibition
In the Monod-Wyman-Changeux (MWC) model of allo-
stery, specific structural interactions preferentially stabi-
lize the tense conformation relative to the relaxed confor-
mation (Monod et al., 1965). If the side chains mediating
these interactions do not have additional roles, then mu-
tating them should shift the equilibrium toward the relaxed
state, increasing activity and reducing positive coopera-
tivity. In unliganded DegS, contacts between the PDZ
domain and the protease domain probably stabilize the
tense/inactive enzyme conformation. In particular, three
salt bridges (D122-R256, R178-E317/D320, and K243-578 Cell 131, 572–583, November 2, 2007 ª2007 Elsevier IncE324) are formed between these domains in unliganded
DegS (Figure 3E) (Wilken et al., 2004; Zeth, 2004). Thus,
in the absence of additional roles, the allosteric model
predicts that mutation of these interface residues will in-
crease basal DegS protease activity and reduce coopera-
tivity. By contrast, the peptide-scaffold model predicts
that disrupting contacts between the PDZ domain and
the protease domain would reduce OMP-stimulated
DegS activity (Wilken et al., 2004).
To test these models, we mutated D122, R178, K243,
R256, E317,D320, andE324, and also inserted anSSIGSS
sequence between R253 and V254 increasing the length
of the linker between the protease domain and the PDZ
domain (designated DegSext). The P183A mutation de-
scribed above also affects an interface contact between
the PDZ and protease domains (Figure 3E). Most interface
Figure 4. Activity of DegS Mutants
(A) Maximum rates of YYF-stimulated cleavage of RseAperi by DegS or
variants with mutations in the LD, L2, or L3 loops.
(B) Maximum rates of cleavage of the RseAperi–YQF fusion substrate
by DegS mutants.
(C) Basal rates of cleavage of RseAperi by DegS and variants with
mutations in the interface or linker between the protease domain and
the PDZ domain.
(D) Maximum rates of YYF-stimulated cleavage of RseAperi by DegS
and interface or linker variants..
Table 3. Activities of DegS and Mutant Variants
Intact DegS
Background
Cleavage of RseAperi Activation by YYF- OMP Peptide Cleavage of RseAperi-YQF
Maximum
YYF-Stimulated
Activity (M1 s1)
Basal
Activity
(M1 s1) Kact (mM)
Hill
Constant
Vmax
(s1 enz1)
KM
(mM)
Wild-type 730 ± 80 2.9 ± 0.5 3.9 ± 0.8 1.8 ± 0.2 0.6 ± 0.02 33 ± 5
D122A 30 ± 5 3.1 ± 0.5 n.d. n.d. 0.18 ± 0.01 20 ± 3
Y162A < 5 n.a. n.d. n.d. n.a. n.a.
Y162F 300 ± 50 n.d. n.d. n.d. 0.28 ± 0.02 48 ± 10
P183A 620 ± 70 18 ± 3 1.6 ± 0.3 1.3 ± 0.2 0.58 ± 0.07 25 ± 4
E227A 1060 ± 80 4.8 ± 0.5 8.8 ± 2.2 1.7 ± 0.1 0.88 ± 0.02 51 ± 7
DegSext 240 ± 30 120 ± 30 n.d. n.d. 0.35 ± 0.03 20 ± 4
E317A 1400 ± 100 8.5 ± 2.7 n.d. n.d. 0.55 ± 0.07 31± 4
D320A 2100 ± 200 100 ± 20 0.2 ± 0.1 y 0.52 ± 0.05 25 ± 5
E324A 780 ± 90 7.2 ± 2.3 2.9 ± 0.5 1.3 ± 0.1 0.47 ± 0.04 32 ± 7
R256A 860 ± 70 470 ± 60 1.2 ± 0.3 1.2 ± 0.3 0.42 ± 0.01 50 ± 3
R256D 510 ± 60 210 ± 30 2.1 ± 0.5 1.2 ± 0.1 0.48 ± 0.01 48 ± 2
K243A 1600 ± 140 14 ± 2 n.d. n.d. 0.52 ± 0.09 34 ± 8
K243D 1700 ± 150 220 ± 30 0.3 ± 0.1 y 0.36 ± 0.01 36 ± 6
R178A 9 ± 2 n.a. n.d. n.d. 0.07 ± 0.01 53 ± 8
DPDZ background
DegSDPDZ 590 ± 60
P183A DegSDPDZ 610 ± 110
E227A DegSDPDZ 1100 ± 200
Y162A DegSDPDZ n.a.
D122A DegSDPDZ 50 ± 10
R178A DegSDPDZ < 5
MaximumYYF-stimulatedactivities andbasal activitiesweredeterminedunder kcat/KMconditionsusingat least threedifferentDegS
and three different RseAperi concentrations. Kact and Hill constants for OMP-peptide activation were determined from two or more
independent experiments like the one shown in Figure 2Awith a fixedRseAperi concentration (200mM). The steady-state parameters
for cleavage of the RseA-YQF substrate are mean values of two or more independent experiments like the one shown in Figure 1F.
n.a., no detectable activity; n.d., not determined. Estimated errors were calculated as described in the Table 1 legend. (y) The OMP-
peptide concentration was too close to the enzyme concentration to determine reliable ‘‘free’’ peptide and thus a Hill constant.mutations (9/11) increased basal cleavage of RseAperi in
the absence ofOMPpeptide (Table 3 and Figure 4C, upper
panel). The K243D, R256A, R256D, and D320A substitu-
tions and the SSIGSS insertion caused the most dramatic
effects, increasing the basal rate of RseAperi cleavage 40-
fold or more. In the cases studied, most mutations that
increased basal protease activity also reduced the coop-
erativity of YYF activation of the cleavage reaction (Hill
constants 1.1–1.4) and reduced the peptide concentration
need for half-maximal activation (Table 3). Moreover, the
majority of interface mutants had OMP-stimulated activi-
ties equal to or greater than wild-type DegS (Table 3 and
Figure 4C, lower panel). Thus, these results support an al-
losteric model in which contacts between the unliganded
PDZ domain and the protease domain constrain DegS to
an inactive conformation.The D122-R256 salt bridge is present in both peptide-
free and peptide-bound DegS (Wilken et al., 2004; Zeth,
2004). Thus, it may seem surprising that the R256D and
R256A mutations shift the allosteric equilibrium in favor
of the relaxed/active DegS conformation. However, the
strength of a salt bridge is determined not only by the in-
teracting side chains but also by net electrostatic interac-
tions with solvent and the rest of the structure (see Shei-
nerman et al., 2000 and references therein). Hence, it is
likely that the D122-R256 salt bridge is stronger in the pep-
tide-free than in the peptide-bound conformation of DegS.
Two of the interface mutations, D122A and R178A,
caused substantial reductions in the activities of DegS
and DegS6PDZ (Table 3). These results suggest that
D122 and R178, which are 99% conserved in DegS ortho-
logs, play additional roles in DegS activity that areCell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc. 579
independent of the PDZ domain. For the R178 variants,
activity ranged from 1%–11% depending on the DegS
background and substrate. For the D122A mutants,
activity was 4%–27% of wild-type. Partial activity of the
D122A DegS mutant was also reported previously (Wilken
et al., 2004). As well as serving an interface role, D122
participates in a hydrogen-bonding network that includes
the main-chain atoms of D126, a nearby active-site resi-
due. These contacts may be necessary for the active
conformation of the catalytic triad, explaining the reduced
activity of the D122A mutant both in DegS and in
DegS6PDZ backgrounds.
R178 is part of the L3 loop. The R178 side chain forms
ion pairs with PDZ residues E317 and D320 in peptide-
free DegS (Figure 3E), but moves19 A˚ andmakes hydro-
gen bonds to the backbone of the LD loop in a neighboring
subunit and to the Q191 side chain in the same subunit in
DegS6PDZ (Figure 3F). The Q191 side chain hydrogen
bonds to the T167 side chain in the adjacent LD loop.
Additional hydrogen bonds form a network that connects
these interactions to the oxyanion hole (Figure 3F). Thus, it
is plausible that repositioning of the R178 side chain is
the key event in the allosteric switch from the inactive to
the active conformation.
R178A Crystal Structure
Although contacts made by the R178 side chain in pep-
tide-bound DegS could stabilize the relaxed/active
conformation of DegS, it is also possible that the R178A
mutant has low activity because it fails to trimerize or as-
sumes an aberrant structure. To address these possibili-
ties, we crystallized R178A DegS6PDZ and solved its
structure (2QGR; 2.7 A˚ resolution). There was only one
DegS6PDZ-R178A subunit in the asymmetric unit, but rhom-
bohedral symmetry in the crystal generated a trimer with
the same quaternary structure observed in the wild-type
enzyme. Most parts of themutant structure were also sim-
ilar to wild-type (rmsd 0.66 A˚ for 625 common main-chain
atoms). However, electron-density for residues 161–165 in
the LD loop and residues 196–201 (including the active site
S201 and oxyanion hole) was poor, and we could not
model both regions without introducing steric clashes or
unacceptable geometry. These regions probably assume
multiple conformations, accounting for the low activity of
the R178A mutant. Thus, the wild-type R178 side chain
appears to play a role both in maintaining the inactive/
tense state of peptide-free DegS and in stabilizing the
active/relaxed conformation of peptide-bound DegS or
DegS6PDZ.
DISCUSSION
The PDZ domains of the intact DegS trimer function as
inhibitory modules. This model was originally suggested
on the basis of genetic studies using the DegS6PDZ variant
(Walsh et al., 2003). Here, we find that the protease activity
of this variant is essentially the same as intact DegS acti-
vated by saturating OMP peptides. Thus, OMP-peptide580 Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc.binding to the PDZ domains activates DegS by relieving
inhibition. We find no evidence for the competing ‘‘scaf-
fold’’ model of activation, in which the PDZ domains func-
tion to present OMP peptides in a fixed orientation to the
DegS protease domain, with the penultimate peptide
side chain playing a key role in activation (Wilken et al.,
2004). For example, we find that YxF peptides with chem-
ically and sterically disparate side chains at the penulti-
mate position (alanine, serine, aspartic acid, glutamine,
arginine, and tyrosine) all activate DegS to roughly the
same extent. We also found that DegS can also be acti-
vated by peptides with other amino acids at the C-terminal
and antepenultimate positions (unpublished data). Thus,
we suspect that almost any C-terminal sequence that
binds to thePDZdomainwill activateDegS. Fromabiolog-
ical perspective, this means that DegS should be able to
sense and respond to the presence of numerous unas-
sembled or misfolded proteins in the periplasm, although
proteins with the highest affinities and abundance will be
the most effective response activators.
Importantly, we find that DegS functions as an allosteric
enzyme. In the tense or inactive conformation, structural
studies show that the active-site triad (H96, D126, amd
S201) and oxyanion hole do not have the proper geometry
for catalysis (Wilken et al., 2004; Zeth, 2004). For example,
in the peptide-free 1te0 structure, the side chains of H96
and S201 are too far apart (4.4 A˚) to form a hydrogen
bond, which is necessary to reduce the pKa and thus to
increase the reactivity of the active-site serine. In the re-
laxed 1soz structure and our DegS6PDZ structures, by
contrast, a hydrogen bond between these side chains
could be formed (average distance 3.46 ± 0.32 A˚; n =
14). Both peptide-bound DegS and DegS6PDZ are inacti-
vated by DFP, and preliminary crystallographic experi-
ments show that Ser201 is the site of modification (unpub-
lished data). However, peptide-free DegS does not react
with DFP, even though its active-site residues are com-
pletely accessible in crystal structures (Wilken et al.,
2004; Zeth, 2004). These structural and biochemical re-
sults show that the small active-site conformational
changes that occur upon OMP-peptide binding or dele-
tion of the PDZ domain improve the nucleophilic character
of the active-site serine.
How do the peptide-free PDZ domains keep DegS inac-
tive? Our results suggest that R178 plays a key role. In the
peptide-free DegS trimer, the R178 side chains in each
subunit bind to the PDZ domains (Wilken et al., 2004;
Zeth, 2004). The precise details of binding are probably
not important, as slightly different contacts are observed
in different crystal structures of unliganded DegS. In pep-
tide-bound DegS or DegS6PDZ, the guanidinium group of
R178moves almost 20 A˚ away from its position in the pep-
tide-free structure and makes a new set of hydrogen-
bonding interactions. Some of these hydrogen bonds
are tomain-chain atoms in the LD loop of an adjacent sub-
unit. Others are to the side chain of Q191, which in turn
contacts the T167 side chain in the adjacent LD loop; pre-
liminary experiments suggest that T167A DegS is 30%
active, whereas Q191A DegS is almost completely inac-
tive. These R178-mediated contacts appear to stabilize
an LD-loop conformation that then stabilizes the active
conformation of the catalytic triad and oxyanion hole
(Figure 3F). In support of this model, we find that the
R178A mutant has low activity both in intact DegS and
in DegS6PDZ. Moreover, the LD-loop and active-site con-
formations are perturbed in our crystal structure of R178A
DegS6PDZ. Thus, we propose that one of the principal
ways in which the peptide-free PDZ domains inhibit
DegS is by binding the R178 side chain.
How does OMP-peptide binding relieve inhibition by the
DegS PDZ domains? If the tense and relaxed forms of
DegS are in dynamic equilibrium, then OMP peptides
would simply need to bind the relaxed structure tightly
enough, compared to binding the tense structure, to tip
the free-energy balance in favor of the relaxed state. In-
deed, superposition of the peptide-bound and peptide-
free PDZ domains reveals strong steric clashes between
the peptide and parts of the peptide-free PDZ domain.
Moreover, we find that OMP peptides bind about 10-fold
more tightly to the isolated PDZ domain than to intact
DegS. Thus, it appears that the relaxed conformation of
the PDZ domain simply binds OMP peptides with higher
affinity than the tense conformation. It will be interesting
to see if peptides or mimics can be designed that bind
preferentially to the tense PDZ conformation, as these
should be potent inhibitors of the envelope-stress re-
sponse in gram-negative bacteria, like E .coli, and might
serve as antibiotics.
Numerous interactions between the unliganded PDZ
domain and the protease domain of DegS contribute to
stabilizing the tense state relative to the relaxed state
(Figure 3E). For example, we found that nine different
mutations in the PDZ domain, in the protease domain, or
in the intradomain linker resulted in increased DegS activ-
ity in the absence of OMP peptides. In other PDZ prote-
ases, interactions between the protease domain and in-
hibitory PDZ domains could easily be very different from
those seen in DegS. Hence, it may be difficult to establish
whether a PDZ domain in a protease plays an inhibitory
role based only on sequence homology.
Positive cooperativity is a hallmark ofmultimeric alloste-
ric enzymes, because binding of one ligand increases the
equilibrium population of relaxed subunits and thus sub-
sequent ligands bind with higher apparent affinity. As
a consequence, binding curves are sigmoidal, and biolog-
ical responses occur over narrower concentration ranges.
We find that the binding of OMP peptides to DegS is pos-
itively cooperative, with a Hill constant near 2. Thus, DegS
activity increases almost 10-fold with a 10-fold increase in
OMP-peptide concentration and vice versa. In a noncoop-
erative system, a 100-fold increase in OMP peptides
would be required to achieve the same activity changes.
We assume that there are always some unassembled
OMPs in the periplasm and, thus, that DegS cleavage of
RseA always occurs at a low level. Indeed, E. coli degS
null mutants are nonviable because RseA inhibition of sEcannot be relieved (Alba et al., 2001). As the concentration
of unassembled or unfolded OMPs increased during
envelope stress, however, DegS cleavage of RseA would
also increase rapidly, ensuring a high-level sE transcrip-
tional response. Similarly, as the levels of unassembled
OMP fell because of degradation or assembly, the stress
response would be turned off more rapidly. Thus, OMPs
or OMP peptides function as allosteric effectors in the
envelope-stress RIP cascade. It will be important to
determine whether the same principles govern other RIP
systems.
We also observe positive cooperativity in the binding
of RseA substrates to DegS, which appears to arise
from substrate-substrate interactions. Once the enve-
lope-stress response is initiated, RseA levels decrease
because of degradation but are also replenished because
expression of the rseA gene levels is stimulated by sE
(Alba and Gross, 2004). Because DegS activity changes
with the approximate square of the RseA concentration,
the rate of cleavage by DegS would slow substantially
as RseA levels in the membrane fell. At a systems level,
this should result in reaching a new steady-state condition
faster, because a lower synthesis rate would be needed to
offset degradation.
Orthologs of DegS, DegP, DegQ, and HtrA2 are trimeric
or hexameric, and thus it is likely that the entire family op-
erates using similar allosteric principles. Indeed, HtrA2
and DegP are both activated by peptide binding, and
deletion of the PDZ domain increases the activity of
HtrA2 (Jones et al., 2002; Li et al., 2002; Martins et al.,
2003; Gupta et al., 2004). Moreover, the oxyanion hole is
malformed in the crystal structures of E. coliDegP, human
HtrA2, and Thermatoga maritima HtrA6PDZ, suggesting
that these structures represent tense, catalytically inactive
states (Clausen et al., 2002; Krojer et al., 2002; Li et al.,
2002; Kim et al., 2003). It will be interesting to see to
what extent the regulatory strategies revealed for DegS
also apply to its relatives.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Mutagenesis
An N-terminally H6-tagged variant of E. coli DegS lacking the mem-
brane anchor (residues 27–355), the same variant without the PDZ
domain (DegS6PDZ; residues 27–256), and the periplasmic domain
of E. coli RseA with a C-terminal H6 tag (RseA
peri; residues 121–216)
were expressed and purified as described (Walsh et al., 2003; Cezair-
liyan and Sauer, 2007). The fusion substrate, with an N-terminal H6 tag
and a C-terminal YQF sequence, was expressed and purified like
RseAperi. Proteins were stored in a buffer containing 50 mM NaHPO4
(pH 8.0), 200 mM NaCl, 10% glycerol, and 4 mM EDTA. Wild-type
DegS, DegSDPDZ, and variants eluted as trimers in gel-filtration chro-
matography. For the expression of radioactive proteins, E. coli
X90DE3 cells were grown in a defined rich medium lacking methionine
(TekNova). At OD600 0.5, IPTG (0.5 mM) to induce expression and
35S-methionine (2 mCi; Perkin-Elmer) were added. Radioactive
RseAperi was purified to > 95% homogeneity as described for the un-
labeled protein. Mutations were generated by the QuikChangemethod
(Stratagene) and confirmed by DNA sequencing. Mutant proteins were
expressed and purified as described for the wild-type counterparts.Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc. 581
Peptides
All peptides were synthesized by the MIT Biopolymer Laboratory,
purified by HPLC, and subjected to MALDI mass-spectrometry. One
set of OMP peptides had free N and C-termini (DNRDGNVYAF,
DNRDGNVYSF, DNRDGNVYDF, DNRDGNVYQF, DNRDGNVYRF,
and DNRDGNVYYF); another set had an N-terminal fluorescein
(fl-bA-KKDNRDGNYYF, fl-DNRDGNVYQF, and fl-bA-KKDNRDGNYAF).
Assays
Degradation, binding, and modification experiments were performed
in reaction buffer (150 mM NaHPO4 [pH 8.3], 380 mM NaCl, 10% glyc-
erol, and 4mMEDTA) at 23 ± 1C. Cleavage reactions were initiated by
addition of enzyme or substrate to reaction buffer with or without OMP
peptide. At each time point, 4 ml of the cleavage reaction was mixed
with 25 ml of 10% TCA. After 20 min on ice, insoluble full-length sub-
strate and the C-terminal cleavage product were separated from the
soluble N-terminal product by centrifugation (16,000 3 g, 20 min,
4C). TCA-soluble fractions were subjected to scintillation counting
to determine the extent of cleavage. The presence of a H6 tag at the
N- or C terminus of substrates did not affect precipitation efficiency
or DegS cleavage rates. Steady-state kinetic parameters were
obtained by fitting data to the standard or Hill forms of the Michae-
lis-Menten equation using the non-linear-least-squares subroutine in
the program KaleidaGraph.
For DFP experiments, DegS or DegSDPDZ (0.7-1.5 mM trimer) were
pre-incubated with 10 mM DFP for 2, 5, and 10 min in the presence
or absence of 40 mM YYF peptide. After these times, the reaction mix-
tures were diluted 25-fold into reaction buffer containing 35 mM YYF
peptide and 150 mM 35S-RseAperi, and the rate of substrate cleavage
was determined. Pre-incubation of these enzymes with 0.4 mM DFP
(the final concentration in the cleavage reaction) showed no inhibition
under any conditions.
Binding experiments monitored by fluorescence anisotropy (excita-
tion 480 nm; emission 520 nm) were performed using a PTI QM-2000-
4SE spectrofluorimeter (Photon Technology International, Birming-
ham, NJ). Fluorescein-labeled OMP peptides were diluted in reaction
buffer to final concentrations of 60-100 nM, and increasing quantities
of DegS or a variant were added. Data were collected for 90 s, aver-
aged, corrected for protein scattering, and fitted with a quadratic
form of a hyperbolic binding equation to determine KD.
Crystallography
Hanging-drop vapor-diffusion crystallization was performed using
DegSDPDZ or R178A DegSDPDZ at 20 mg/ml concentrations in 50 mM
NaHPO4 (pH 8.0), 200 mM NaCl, 5 mM EDTA, and 10% glycerol.
Hampton Research Crystal Screens I and II and PEG-Ion screen
were used for initial screening. The first DegSDPDZ crystal form
(2QF0) was grown at 20 C by mixing the protein stock 1:1 with crys-
tallization solution (50 mM sodium cacodylate, [pH 6], 150 mM sodium
citrate, and 15% isopropanol). For cryoprotection, 1 ml of 50%MPD in
well solution was added directly to4 ml drops containing crystals; af-
ter 10 min, crystals were frozen in liquid nitrogen. DegSDPDZ 2QF3
crystals were obtained from Hampton Screen-II condition 27 (0.1 M
Tris, [pH 8.5], 40% MPD, and 0.01 M ammonium phosphate monoba-
sic) after two months and were frozen without cryoprotection. The
R178A DegSDPDZ crystals were obtained in two weeks using 50 mM
sodium cacodylate (pH 6), 100 mM sodium citrate, and 20% isopropa-
nol at 20C, and were frozen without cryoprotection.
A Rigaku MicroMax007-HF rotating anode source equipped with
Varimax-HR mirrors, a RAXIS-IV detector, and an X-Stream cryo-sys-
tem was used to screen frozen crystals and collect data for the 2QGR
DegSDPDZ crystal. SAD data (l = 0.97918 A˚) from a Se-methionine
crystal of DegSDPDZ (2QF0) were collected at the NE-CAT 24-ID-C
beamline at the Argonne National Labs Advanced Photon Source. A
total of 26 of 27 possible selenium sites were located using the
HKL2MAP interface to SHELX (Pape and Schneider, 2004). The validity
of sites was confirmed by the interpretability of the density modified582 Cell 131, 572–583, November 2, 2007 ª2007 Elsevier Inc.(DM) map produced by HKL2MAP. These sites were input into au-
toSHARP (Vonrhein et al., 2006), which located the single missing
site, and was used to refine sites, calculate experimental phases,
and refine phases by density modification. The resulting DM map
was used to build an initial model with COOT (Emsley & Cowtan,
2004), which was refined using CNS (Bru¨nger et al., 1998) with iterative
rebuilding in COOT. A trimeric search model was constructed from the
refinedmodel by removing loops with variable conformations from one
of the three trimers in the asymmetric unit. This searchmodel was used
to obtain molecular-replacement phases for the 2QF3 crystal (data
collected at the 24-ID-C beamline) using AMoRe (Navaza, 1994) and
the 2QGR crystal using PHASER (Storoni et al., 2004). Both structures
were also built and refined with COOT and CNS.
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